InvestorsHub Logo
Followers 23
Posts 2188
Boards Moderated 0
Alias Born 03/18/2013

Re: CaptBeer post# 400506

Wednesday, 02/01/2023 1:57:25 PM

Wednesday, February 01, 2023 1:57:25 PM

Post# of 426070
Thanks Capt; So it's a process, From yesterdays Post/ interview of Alex Denner and David Faber (CNBC) 2017? AD mentions MEDCO. He also mentioned that MEDCO had several losing drugs that were sold. He said he had to jettison them because they were losing money and it was a drag on the company. He had kept Inclisiran (Leqvio) as it was the only viable drug that had any value. Which we all know Novartis took the bait.
As the case with Amarin, we are relatively simple in comparison. We only have the one viable drug, which in IMHO trumps Inclirsiran. Conversely our timeline will be much shorter than MEDCO's. All in IMHO.

So, using your chart, from March 2018 when Denner gains control of the MEDCO BOD to November 24, 2019, is almost two years. I would guess, we'll see something 6 months to 1 year Max.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News